FDA Inspection
Kaysersberg Pharmaceuticals SASFDA Inspection 981303 - Kaysersberg Pharmaceuticals SAS - July 19, 2016
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Kaysersberg Pharmaceuticals SAS, with an inspection on July 19, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · 107d2a0c-87ae-4a0f-95a0-14a5eb7bcbc2
Violation Codes8
21 CFR 211.100(b)21 CFR 211.110(a)21 CFR 211.160(b)21 CFR 211.19221 CFR 211.42(c)(10)(iv)21 CFR 211.56(b)21 CFR 211.67(b)21 CFR 211.68(a)
Full citation text and observation details available on the Dashboard.